Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled dose-exploration study of Dayinqiao Granules for common cold (wind-heat pattern) with moderate to severe fever
CTR20242217Phase 2Completed
- Sponsor
- Huixian Baiquan Traditional Chinese Medicine Research and Development
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of shuangqiao ganmao granules in nasopharyngitis, sponsored by Huixian Baiquan Traditional Chinese Medicine Research and Development. Started Nov 2024; status: completed.
02
Drugs
shuangqiao ganmao granules
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on CTR20242217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242217.